Submission for Office of Management and Budget Review; Behavioral Interventions To Advance Self-Sufficiency-Next Generation (BIAS-NG) (Office of Management and Budget #0970-0502), 66115-66117 [2024-18065]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 157 / Wednesday, August 14, 2024 / Notices
persons contact ACAESH@fhfa.gov.
Individuals who wish to attend virtually
may request a link to the virtual meeting
platform. Due to limited seating
availability, members of the public who
wish to attend are encouraged to
consider attending virtually. Attendees
who require reasonable accommodation
should make their requests by
September 6, 2024. Requests received
after that date will be considered but
may not be possible to accommodate.
Additionally, for security reasons,
members of the public will be subject to
security screening procedures and must
present valid photo identification to
enter the building.
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of Committee Charter Renewal
and Objectives and Duties of the
Committee
Pursuant to the FACA (5 U.S.C.
chapter 10), FHFA announces the
renewal of the charter of the Committee.
The purpose of the Committee is to
advise FHFA in the exercise of its
oversight functions regarding affordable,
equitable, and sustainable housing,
including but not limited to, affordable,
equitable, and sustainable housing
needs, barriers to access, barriers to
long-term sustainability, and any
regulatory, guidance, or policy changes
that may be necessary or beneficial to
expand such housing. The Committee
will focus on FHFA’s regulated
entities—Fannie Mae, Freddie Mac, and
the Federal Home Loan Banks—and
their respective roles in providing a
reliable source of liquidity and funding
to support housing finance and
community investment in the singlefamily and multifamily housing
markets.
The duties of the Committee are
solely advisory and extend only to its
submission of advice and
recommendations to FHFA, with
supporting information and analysis,
which are non-binding on FHFA.
No determinations of fact or policy
are be made by the Committee. The
Committee has no decision-making role,
and will have no access to non-public
FHFA information, including
confidential supervisory or other
confidential information.
Membership of the Committee
The FHFA Director will continue to
appoint the members of the Committee
as their terms expire. To achieve a fairly
balanced membership, FHFA will
continue to seek members
representative of diverse communities,
points of view, institution asset sizes,
and geographical locations, with
expertise in affordable, sustainable, or
equitable housing in single-family and
VerDate Sep<11>2014
18:22 Aug 13, 2024
Jkt 262001
multifamily housing. The Committee
will include members with expertise,
applicable to Fannie Mae, Freddie Mac,
or the Federal Home Loan Banks, in the
areas related to the duties and
authorities of the Committee, such as:
(1) fair lending, fair housing, or civil
rights; (2) single-family lending,
servicing, development, mortgages, or
capital markets; (3) multifamily lending,
servicing, development, mortgages,
capital markets, or investments (i.e.
Low-Income Housing Tax Credits); (4)
consumer, tenant, or community
advocacy; (5) housing market
technology; (6) state, local, or tribal
government housing policies and
programs; and (7) academic or nonacademic affiliated housing research.
The Committee consists of
approximately 20 members, serving
two-year terms. Members serve at the
sole discretion of the Director.
The Committee will meet regularly, as
required to carry out its functions. It is
estimated that the Committee will meet
at least twice per year. Generally,
Committee meetings will be open to the
public.
Sandra L. Thompson,
Director, Federal Housing Finance Agency.
[FR Doc. 2024–18116 Filed 8–13–24; 8:45 am]
BILLING CODE 8070–01–P
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
66115
Comments received are subject to
public disclosure. In general, comments
received will be made available without
change and will not be modified to
remove personal or business
information including confidential,
contact, or other identifying
information. Comments should not
include any information such as
confidential information that would not
be appropriate for public disclosure.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than August 29, 2024.
A. Federal Reserve Bank of St. Louis
(Holly A. Rieser, Senior Manager) P.O.
Box 442, St. Louis, Missouri 63166–
2034. Comments can also be sent
electronically to
Comments.applications@stls.frb.org:
1. Suzanne L. Shaw, Greensburg,
Pennsylvania; to join the Croftcheck
Family Control Group, a group acting in
concert, to acquire voting shares of
Townsend Financial Corporation, and
thereby indirectly acquire voting shares
of Farmers Bank, both of Parsons,
Tennessee.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2024–18139 Filed 8–13–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget Review; Behavioral
Interventions To Advance SelfSufficiency-Next Generation (BIAS–
NG) (Office of Management and Budget
#0970–0502)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families, U.S. Department
of Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Office of Planning,
Research, and Evaluation (OPRE) in the
Administration for Children and
Families (ACF), U.S. Department of
Health and Human Services (HHS)
requests Office of Management and
Budget (OMB) approval to modify and
extend the approval of the ACF
Behavioral Interventions to Advance
SUMMARY:
E:\FR\FM\14AUN1.SGM
14AUN1
66116
Federal Register / Vol. 89, No. 157 / Wednesday, August 14, 2024 / Notices
Self-Sufficiency-Next Generation
(BIAS–NG) Project Overarching Generic
(OMB #: 0970–0502; Expiration date:
8/31/2025.) Under this overarching
clearance, ACF collects data as part of
rapid cycle testing and evaluation, to
inform the design of interventions
informed by behavioral science and to
better understand the mechanisms and
effects of such interventions.
Interventions have been and will
continue to be developed in the program
area domains of Temporary Assistance
for Needy Families (TANF), child
welfare, and Early Head Start/Head Start
(EHS/HS). This revision would also
allow for collection of data in the child
care program area, and would extend
the approval of the overarching generic.
These interventions are intended to
improve outcomes for participants in
these programs.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing
OPREinfocollection@acf.hhs.gov.
Identify all requests by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: OPRE is conducting the
BIAS–NG project, which uses
behavioral insights to design and test
interventions intended to improve the
efficiency, operations, and efficacy of
human services programs. The BIAS–
NG project is applying and testing
behavioral insights to ACF programs
including TANF, child welfare, and
EHS/HS, and intends to expand these
efforts to child care. This notice is a
request for comments on ACF’s proposal
to revise and extend a previously
approved collection, which included
data collection to design and test
interventions in the TANF, child
welfare, and EHS/HS domains. Under
the approved pilot generic clearance,
OPRE has already conducted work with
seven sites to conduct seven tests, and
is planning to continue to work with at
least one additional site, conducting one
or more tests of behavioral interventions
for a total of nine tests of behavioral
interventions. All approved information
collection activities can be found here:
https://www.reginfo.gov/public/do/
PRAICList?ref_nbr=202206-0970-002.
In addition to extending approval,
this approval would also allow OPRE to
conduct tests in the newly added
program area of child care. The design
and testing of BIAS–NG interventions is
rapid and, to the extent possible,
iterative. Each specific intervention is
designed in consultation with agency
leaders and launched as quickly as
possible. To maximize the likelihood
that the intervention produces
measurable, significant, and positive
effects on outcomes of interest, rapid
cycle evaluation techniques will be
employed in which proximate outcomes
will be measured to allow the research
team to more quickly iterate and adjust
the intervention design, informing
subsequent tests. Due to the rapid and
iterative nature of this work, OPRE
sought and received approval for an
overarching generic clearance to
conduct this research. Following
standard OMB requirements for generic
clearances, once instruments subject to
PRA are tailored to a specific site and
the site’s intervention, OPRE submits an
individual generic information
collection request under this umbrella
clearance. Each request includes the
individual instrument(s), a justification
specific to the individual information
collection, a description of the proposed
intervention, and any supplementary
documents. Each specific information
collection includes up to two
submissions—one submission for the
formative stage research and another
submission for any further data
collection requiring burden during the
testing phase. The type of information to
be collected and the uses of the
information is described in the
supporting statements, found here:
https://www.reginfo.gov/public/do/
PRAViewDocument?ref_nbr=2022060970-002.
Respondents: (1) Program
Administrators, (2) Program Staff, and
(3) Program Clients.
ANNUAL BURDEN ESTIMATES
[TANF, child welfare, EHS/HS, child care]
Number of
respondents
(TANF, CW,
EHS/HS, CC)
(total over
request
period)
Instrument
Number of
responses per
respondent
(total over
request
period)
Average
burden per
response
(in hours)
Total burden
(in hours)
Annual
burden
(in hours)
Phase 3: Diagnosis and Design
ddrumheller on DSK120RN23PROD with NOTICES1
Administrator interviews/focus groups .................................
Staff interviews/focus groups ...............................................
Client interviews/focus groups .............................................
Client survey ........................................................................
Staff Survey .........................................................................
48
400
400
400
400
1
1
1
1
1
1
1
1
.25
.25
48
400
400
100
100
16
133
133
33
33
1
1
1
1
1
1
1
1
.25
.25
96
800
800
3,000
300
32
267
267
1,000
100
Phase 4: Evaluation
Administrator interviews/focus groups .................................
Staff interviews/focus groups ...............................................
Client interviews/focus groups .............................................
Client survey ........................................................................
Staff Survey .........................................................................
VerDate Sep<11>2014
18:22 Aug 13, 2024
Jkt 262001
PO 00000
Frm 00087
96
800
800
12,000
1,200
Fmt 4703
Sfmt 4703
E:\FR\FM\14AUN1.SGM
14AUN1
Federal Register / Vol. 89, No. 157 / Wednesday, August 14, 2024 / Notices
Electronic Submissions
Estimated Total Annual Burden
Hours: 2,014.
Authority: 42 U.S.C. 1310.
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024–18065 Filed 8–13–24; 8:45 am]
BILLING CODE 4184–07–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2024–N–3677]
International Drug Scheduling; Single
Convention on Narcotic Drugs;
Convention on Psychotropic
Substances; Hexahydrocannabinol; NPyrrolidino Protonitazene
(Protonitazepyne); N-Pyrrolidino
Metonitazene (Metonitazepyne); NPiperidinyl Etonitazene
(Etonitazepipne); N-Desethylisotonitazene; 3-Hydroxyphencyclidine; N-Ethylheptedrone;
Carisoprodol; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; request for comments.
ddrumheller on DSK120RN23PROD with NOTICES1
Written/Paper Submissions
The Food and Drug
Administration (FDA or Agency) is
inviting interested persons to submit
comments concerning abuse potential,
actual abuse, medical usefulness,
trafficking, and impact of scheduling
changes on availability for medical use
of eight drug substances. These
comments will be considered in
preparing a response from the United
States to the World Health Organization
(WHO) regarding the abuse liability and
diversion of these drugs. WHO will use
this information to consider whether to
recommend that certain international
restrictions be placed on these drug
substances. This notice requesting
comments is required by the Controlled
Substances Act (CSA).
DATES: Either electronic or written
comments must be submitted by August
23, 2024.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
August 21, 2024. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
SUMMARY:
VerDate Sep<11>2014
18:22 Aug 13, 2024
Jkt 262001
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2024–N–3677 for ‘‘International Drug
Scheduling; Single Convention on
Narcotic Drugs; Convention on
Psychotropic Substances;
Hexahydrocannabinol (HHC); NPyrrolidino Protonitazene
(Protonitazepyne); N-Pyrrolidino
Metonitazene (Metonitazepyne); NPiperidinyl Etonitazene
(Etonitazepipne); N-Desethylisotonitazene; 3-Hydroxy-phencyclidine
(3–OH–PCP); N-Ethylheptedrone;
Carisoprodol; Request for Comments’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
66117
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Edward (Greg) Hawkins, Center for Drug
Evaluation and Research, Controlled
Substance Staff, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 5110, Silver Spring,
MD 20993–0002, 301–796–0727,
edward.hawkins@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The United States is a party to the
1971 Convention on Psychotropic
Substances (Psychotropic Convention).
Article 2 of the Psychotropic
Convention provides that if a party to
the convention or WHO has information
about a substance, which in its opinion
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 89, Number 157 (Wednesday, August 14, 2024)]
[Notices]
[Pages 66115-66117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18065]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for Office of Management and Budget Review; Behavioral
Interventions To Advance Self-Sufficiency-Next Generation (BIAS-NG)
(Office of Management and Budget #0970-0502)
AGENCY: Office of Planning, Research, and Evaluation, Administration
for Children and Families, U.S. Department of Health and Human
Services.
ACTION: Request for public comments.
-----------------------------------------------------------------------
SUMMARY: The Office of Planning, Research, and Evaluation (OPRE) in the
Administration for Children and Families (ACF), U.S. Department of
Health and Human Services (HHS) requests Office of Management and
Budget (OMB) approval to modify and extend the approval of the ACF
Behavioral Interventions to Advance
[[Page 66116]]
Self-Sufficiency-Next Generation (BIAS-NG) Project Overarching Generic
(OMB #: 0970-0502; Expiration date: 8/31/2025.) Under this overarching
clearance, ACF collects data as part of rapid cycle testing and
evaluation, to inform the design of interventions informed by
behavioral science and to better understand the mechanisms and effects
of such interventions. Interventions have been and will continue to be
developed in the program area domains of Temporary Assistance for Needy
Families (TANF), child welfare, and Early Head Start/Head Start (EHS/
HS). This revision would also allow for collection of data in the child
care program area, and would extend the approval of the overarching
generic. These interventions are intended to improve outcomes for
participants in these programs.
DATES: Comments due within 30 days of publication. OMB must make a
decision about the collection of information between 30 and 60 days
after publication of this document in the Federal Register. Therefore,
a comment is best assured of having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. You can
also obtain copies of the proposed collection of information by
emailing [email protected]. Identify all requests by the
title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: OPRE is conducting the BIAS-NG project, which uses
behavioral insights to design and test interventions intended to
improve the efficiency, operations, and efficacy of human services
programs. The BIAS-NG project is applying and testing behavioral
insights to ACF programs including TANF, child welfare, and EHS/HS, and
intends to expand these efforts to child care. This notice is a request
for comments on ACF's proposal to revise and extend a previously
approved collection, which included data collection to design and test
interventions in the TANF, child welfare, and EHS/HS domains. Under the
approved pilot generic clearance, OPRE has already conducted work with
seven sites to conduct seven tests, and is planning to continue to work
with at least one additional site, conducting one or more tests of
behavioral interventions for a total of nine tests of behavioral
interventions. All approved information collection activities can be
found here: https://www.reginfo.gov/public/do/PRAICList?ref_nbr=202206-0970-002.
In addition to extending approval, this approval would also allow
OPRE to conduct tests in the newly added program area of child care.
The design and testing of BIAS-NG interventions is rapid and, to the
extent possible, iterative. Each specific intervention is designed in
consultation with agency leaders and launched as quickly as possible.
To maximize the likelihood that the intervention produces measurable,
significant, and positive effects on outcomes of interest, rapid cycle
evaluation techniques will be employed in which proximate outcomes will
be measured to allow the research team to more quickly iterate and
adjust the intervention design, informing subsequent tests. Due to the
rapid and iterative nature of this work, OPRE sought and received
approval for an overarching generic clearance to conduct this research.
Following standard OMB requirements for generic clearances, once
instruments subject to PRA are tailored to a specific site and the
site's intervention, OPRE submits an individual generic information
collection request under this umbrella clearance. Each request includes
the individual instrument(s), a justification specific to the
individual information collection, a description of the proposed
intervention, and any supplementary documents. Each specific
information collection includes up to two submissions--one submission
for the formative stage research and another submission for any further
data collection requiring burden during the testing phase. The type of
information to be collected and the uses of the information is
described in the supporting statements, found here: https://www.reginfo.gov/public/do/PRAViewDocument?ref_nbr=202206-0970-002.
Respondents: (1) Program Administrators, (2) Program Staff, and (3)
Program Clients.
Annual Burden Estimates
[TANF, child welfare, EHS/HS, child care]
----------------------------------------------------------------------------------------------------------------
Number of Number of
respondents responses per
(TANF, CW, EHS/ respondent Average burden Total burden Annual burden
Instrument HS, CC) (total (total over per response (in hours) (in hours)
over request request (in hours)
period) period)
----------------------------------------------------------------------------------------------------------------
Phase 3: Diagnosis and Design
----------------------------------------------------------------------------------------------------------------
Administrator interviews/focus 48 1 1 48 16
groups.........................
Staff interviews/focus groups... 400 1 1 400 133
Client interviews/focus groups.. 400 1 1 400 133
Client survey................... 400 1 .25 100 33
Staff Survey.................... 400 1 .25 100 33
----------------------------------------------------------------------------------------------------------------
Phase 4: Evaluation
----------------------------------------------------------------------------------------------------------------
Administrator interviews/focus 96 1 1 96 32
groups.........................
Staff interviews/focus groups... 800 1 1 800 267
Client interviews/focus groups.. 800 1 1 800 267
Client survey................... 12,000 1 .25 3,000 1,000
Staff Survey.................... 1,200 1 .25 300 100
----------------------------------------------------------------------------------------------------------------
[[Page 66117]]
Estimated Total Annual Burden Hours: 2,014.
Authority: 42 U.S.C. 1310.
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024-18065 Filed 8-13-24; 8:45 am]
BILLING CODE 4184-07-P
